Skip to content
Clinical Trials – home
Institut Bergonie
Sponsor

Institut Bergonie

France 229 Cours De L Argonne, 33000 Bordeaux, France

About the sponsor

Clinical research at Institut Bergonie is strongly centered on soft-tissue sarcoma, including leiomyosarcoma, undifferentiated pleomorphic sarcoma, and resectable or advanced disease. The portfolio also includes osteosarcoma and Ewing sarcoma, with interest in both localized and metastatic settings.

  • Advanced soft-tissue sarcoma
  • Leiomyosarcoma
  • Undifferentiated pleomorphic sarcoma
  • Osteosarcoma and Ewing sarcoma

Research activity spans neoadjuvant, peri-operative, and metastatic sarcoma care, with attention to surgical disease, recurrence risk, and progression control.

About Specializations

Institut Bergonie runs clinical trials in conditions such as Soft tissue sarcoma, Neoplasm, Malignant fibrous histiocytoma, Neoplasm malignant, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

13 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dacarbazine
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ifosfamide
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Institut Bergonie

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Berzosertib
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ezabenlimab
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Institut Bergonie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Volrustomig
  • Sponsor:Institut Bergonie

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.